Cell Carcinoma Clinical Trial
— RaP E ToCOfficial title:
An Evaluation of the Radio/Pathological Correlation of Depth Of Invasion for Oral Squamous Cell Carcinoma, a Retrospective Study in a University Hospital in Lyon
| NCT number | NCT04821128 |
| Other study ID # | 242 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | November 27, 2020 |
| Est. completion date | May 27, 2021 |
The aim of the study is to assess the good correlation and prediction of the DOI for the post-operative pathological results and prognosis.
| Status | Recruiting |
| Enrollment | 200 |
| Est. completion date | May 27, 2021 |
| Est. primary completion date | November 27, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion Criteria: - patients chirurgically treated for an OSCC - T1 T2 T3 - CT scanner in their medical file Exclusion Criteria: - T4 - R+ résection - Artefacts on CT scanner |
| Country | Name | City | State |
|---|---|---|---|
| France | Croix rousse hospital | Lyon |
| Lead Sponsor | Collaborator |
|---|---|
| Hospices Civils de Lyon |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The primary outcome will be the measure of the correlation of the depth of invasion on the radiological pre operative images and of the pathological analyses on the resection piece. | With a Bland Altman analysis we will assess the good correlation between the pre and post operatory mesures of the depth of invasion in the oral squamous cell carcioma | The outcome will be measured at the inclusion of the patient in the current study. |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06112522 -
Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma
|
Phase 2 | |
| Recruiting |
NCT05623748 -
Establishment and Application of 3-Dimensional (3-D) Cell Culture Model of Clinical Circulating Tumor Cells (CTCs)
|